Status:

COMPLETED

Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease

Lead Sponsor:

Harokopio University

Collaborating Sponsors:

University of Athens

Conditions:

Non-alcoholic Fatty Liver Disease (NAFLD)

Non-alcoholic Steatohepatitis (NASH)

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Non-alcoholic fatty liver disease (NAFLD) is considered as the hepatic manifestation of the metabolic syndrome. NAFLD is a pathologic condition which involves both hepatic steatosis and non alcoholic ...

Detailed Description

Non-alcoholic fatty liver disease (NAFLD) is a pathologic condition which involves both hepatic steatosis and non alcoholic steatohepatitis (NASH), as the result of fat accumulation in the liver (live...

Eligibility Criteria

Inclusion

  • The inclusion criteria will be:
  • Participants aged 18-65 years old,
  • Participants with non-alcoholic fatty liver disease (NAFLD). NAFLD's diagnosis will be based on increased serum levels of alanine aminotransferase (ALT) above 1.5 times, with or without increased gamma-glutamyl transpeptidase (GGT) serum levels,
  • BMI \>25 Kg/m2 (range 25-40 Kg/m2),
  • The presence of hepatic steatosis and absence of other causes of hepatic steatosis and hepatic failure.

Exclusion

  • The exclusion criteria will be:
  • Detection of hepatitis B surface antigen (HBsAg) or antibodies against hepatitis C(anti-HCV) or antibodies against HIV,
  • Alcohol intake \>210 or \>140 gr per week for men or women, respectively,
  • Reception of potentially hepatotoxic drugs,
  • Presence of systemic disease with potential liver involvement,
  • Diabetes mellitus.

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2017

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT01894438

Start Date

April 1 2013

End Date

May 1 2017

Last Update

August 3 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Harokopio University

Kallithea, Attica, Greece, 17671

Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease | DecenTrialz